Israel: Three Participants Complete 12-Month Follow-Up

On February 2 and February 7, 2017, the eighth and ninth of 10 participants completed their 12-month follow-up interviews in our Israeli Phase 2 study of MDMA-assisted psychotherapy for PTSD. The seventh …

Israel: Two Participants Complete 12-Month Follow-Up

On November 10 and November 28, 2016, the fifth and sixth of 10 participants completed their 12-month follow-up interviews in ourIsraeli Phase 2 study of MDMA-assisted psychotherapy for PTSD. Led by Principal …

Israel: Fourth Participant Completes 12-Month Follow-Up

On October 21, 2016, the fourth of 10 participants completed their 12-month follow-up interview in our Israeli Phase 2 study of MDMA-assisted psychotherapy for PTSD. Led by Principal Investigator Moshe …

Israel: Final Experimental Treatment Completed

On March 24, 2016, the final open label experimental treatment session was completed in our Israeli Phase 2 study of MDMA-assisted psychotherapy for PTSD. In addition to being the final experimental …

Israel: Last Participant Receives First Treatment

On January 13, 2016, the tenth and final subject received their first treatment in our Israeli Phase 2 study of MDMA-assisted psychotherapy for PTSD. Led by Principal Investigator Moshe Kotler, M.D., this …

Israel: Ninth Participant Treated; Enrollment Completed

On December 10, 2015, the ninth participant was treated in our Israeli study of MDMA-assisted psychotherapy for PTSD. The tenth and final participant was enrolled on December 16. Led by Principal Investigator …

Israel: Ninth Subject Enrolled

On November 4, 2015, the ninth subject was enrolled in our ongoing Israeli study of MDMA-assisted psychotherapy for PTSD. Led by Principal Investigator Moshe Kotler, M.D., this Phase 2 study will treat …

Israel: Eighth Subject Treated

On October 6, the eighth subject was treated in our ongoing Israeli study of MDMA-assisted psychotherapy for PTSD. Led by Principal Investigator Moshe Kotler, M.D., this Phase 2 study will treat up to …

Israel: Eighth Subject Enrolled

On September 4, 2015, the eighth subject was enrolled in our ongoing Israeli study of MDMA-assisted psychotherapy for PTSD. Led by Principal Investigator Moshe Kotler, M.D., this Phase 2 study will treat …

Israel: Fifth Subject Treated, One More Enrolled

On July 14, 2015, the fifth subject was treated in our ongoing Israeli study of MDMA-assisted psychotherapy for PTSD. The seventh subject was enrolled on July 23. Led by Principal Investigator Moshe Kotler, …

Israel: Two More Subjects Enrolled

On June 24 and 25, 2015, the fifth and sixth subjects were enrolled in our ongoing Israeli study of MDMA-assisted psychotherapy for PTSD. Led by Principal Investigator Moshe Kotler, M.D., this Phase 2 …